Bone Marrow Research / 2013 / Article / Tab 4

Clinical Study

Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation

Table 4

Multivariate analysis overall survival and progression-free survival.

Variables at day 100 post-APBHSCTOverall survivalProgression-free survival
HR95% CI HR95% CI

Female versus male0.740.28–1.870.9
Albumin ≥ 40.980.31–3.710.90.820.32–1.950.7
ALC ≥ 0.6 cells/µL0.420.14–1.300.10.570.24–1.410.2
Hemoglobin < 10.5 g/dL1.240.33–4.540.71.060.41–2.690.9
IPS ≥ 31.830.45–8.170.42.020.67–6.400.2
WBC > 15 cells/µL1.280.32–4.780.71.300.47–3.650.6
Day 15 ALC ≥ 0.5 cells/µL0.290.07–1.120.070.460.21–0.99<0.05
Day 100 ALC ≥ 0.8 cells/µL0.550.20–1.420.20.540.25–1.160.1
Day 100 AMC ≥ 0.63 cells/µL1.830.71–4.910.21.650.65–4.230.3
Day 100 ALC/AMC ≥ 1.30.330.12–0.85<0.020.370.18–0.72<0.004

Abbreviations: ALC: absolute lymphocyte count; AMC: absolute monocyte count; IPS: international prognostic score; WBC: white blood cell count.

You are browsing a BETA version of Hindawi.com. Click here to switch back to the original design.